Drug Combination in Clinical Cancer Treatments
文献类型:期刊论文
作者 | Lu, Da-Yong2; Lu, Ting-Ren3; Yarla, Nagendra Sastry4; Wu, Hong-Ying3; Xu, Bin5![]() ![]() |
刊名 | Reviews on recent clinical trials
![]() |
出版日期 | 2017 |
卷号 | 12期号:3页码:202-211 |
ISSN号 | 1876-1038 |
DOI | 10.2174/1574887112666170803145955 |
文献子类 | Article;Review |
英文摘要 | The modality of anticancer drug combinations needs to be renovated from empirical into technical-supportive systems. |
语种 | 英语 |
源URL | [http://119.78.100.183/handle/2S10ELR8/266769] ![]() |
专题 | 院士及顾问专家 药理学第一研究室 |
作者单位 | 1.College of Pharmaceutical Science, Zhejiang University, Hangzhou. China 2.School of Life Sciences, Shanghai University, Shanghai 200444. China; 3.College of Science, Shanghai University, Shanghai200444. China; 4.GITAM University, Viskhatnam, AP. India; 5.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai201203. China; |
推荐引用方式 GB/T 7714 | Lu, Da-Yong,Lu, Ting-Ren,Yarla, Nagendra Sastry,et al. Drug Combination in Clinical Cancer Treatments[J]. Reviews on recent clinical trials,2017,12(3):202-211. |
APA | Lu, Da-Yong.,Lu, Ting-Ren.,Yarla, Nagendra Sastry.,Wu, Hong-Ying.,Xu, Bin.,...&Zhu, Hong.(2017).Drug Combination in Clinical Cancer Treatments.Reviews on recent clinical trials,12(3),202-211. |
MLA | Lu, Da-Yong,et al."Drug Combination in Clinical Cancer Treatments".Reviews on recent clinical trials 12.3(2017):202-211. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。